Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The USS Center of Cell Therapy G. Lanzani (CTC-USS) is a specialized biotechnology and clinical research center based at the Universidad San Sebastián in Chile. The center focuses on the development and application of advanced therapies, particularly mesenchymal stem cell (MSC) treatments and secretome-based products for regenerative medicine. Its primary business involves conducting clinical trials and providing cell-based therapeutic solutions for conditions such as osteoarthritis and chronic wounds. CTC-USS operates with high-standard laboratory facilities to process and characterize cellular products for clinical use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on USS Center of Cell Therapy G. Lanzani.